Patienta (age/sex) | Indications For transplant | Graft | Stricture morphology | Tip shape of the distal duct | ERCP (No) | Endoscopic Treatment Success | Number of strictures | Inside Stent (times) | Outside Stent (times) | Stent indwelling period (months) | Follow Up period (months) | Present status |
---|---|---|---|---|---|---|---|---|---|---|---|---|
30–39/sex 1 | Fulminant liver failure | Left | Non-visualization | Round | 1 | No | 1 | 0 | 0 | 0 | 108 | Choledochojejunostomy |
30–39/sex 2 | Fulminant liver failure | Left | Wide | Tapered | 14 | Yes | 1 | 11 | 1 | 105 | 105 | Inside stent |
50–59/sex 2 | LC-PBC | Left | Separate | Round | 8 | Yes | 1 | 8 | 0 | 85 | 85 | Inside stent |
60–69/sex 2 | LC-HBV | Left | Narrow | Tapered | 7 | Yes | 1 | 7 | 0 | 42 | 56 | Stricture resolution |
50–59/sex 1 | LC-HCV | Left | Narrow | Tapered | 5 | Yes | 1 | 3 | 0 | 19 | 35 | Stricture resolution |
60–69/sex 1 | LC-HCV | Left | Narrow | Tapered | 5 | Yes | 1 | 3 | 1 | 23 | 23 | Inside stent |
60–69/sex 2 | LC-PBC | Left | Narrow | Round | 3 | Yes | 1 | 3 | 0 | 16 | 16 | Inside stent |
50–59/sex 1 | LC-HBV | Right | Narrow | Tapered | 7 | Yes | 1 | 5 | 2 | 58 | 127 | Stricture resolution |
40–49/sex 1 | LC-HBV | Right | Non-visualization | Round | 1 | No | 2 | 0 | 0 | 0 | 124 | Choledochojejunostomy |
50–59/sex 1 | LC-HCV | Right | Narrow | Tapered | 8 | Yes | 2 | 5 | 2 | 17 | 93 | Stricture resolution |
40–49/sex 1 | LC-NASH | Right | Separate | Round | 6 | Yes | 2 | 6 | 0 | 84 | 84 | Inside stent |
60–69/sex 1 | LC-alcohol | Right | Separate | Tapered | 5 | Yes | 2 | 3 | 1 | 70 | 78 | Stricture resolution |
50–59/sex 1 | LC-alcohol | Right | Separate | Tapered | 6 | Yes | 1 | 6 | 0 | 61 | 61 | Inside stent |
60–69/sex 2 | LC-HCV | Right | Separate | Tapered | 4 | Yes | 1 | 4 | 0 | 19 | 52 | Stricture resolution |
50–59/sex 2 | LC-PBC | Right | Narrow | Tapered | 6 | Yes | 2 | 3 | 3 | 27 | 45 | Stricture resolution |
60–69/sex 1 | LC-HCV | Posterior | Separate | Round | 12 | Yes | 1 | 12 | 0 | 87 | 87 | Inside stent |